chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received the first dose of Moderna COVID vaccine on 1/11/2021. It was documented in her immunization record. She was admitted to a nursing facility on 1/13/2021 for short term rehab. Her vaccination records were sent with her when she was admitted to the nursing facility.  She then received a dose of the Pfizer COVID vaccine on 1/28/2021.
Information has been received from a consumer, a 74-year-old female, registered nurse with penicillin allergy, who in August of 2007 was vaccinated subcutaneously with a dose of ZOSTAVAX. Concomitant therapy included estrogens, PREMPRO. On approximately 20-SEP-2007, "3 weeks ago", the patient broke out in shingles. She stated that it was very painful. Medical treatment was sought and she was treated with steroids. The outcome was reported as recovering. No product quality complaint was involved. Additional information has been requested.
Site of injection extremely sore after approximately 6 hours. The first night, migraine headache. 2nd day into 2nd night, headache, fever (101), chills, malaise, extreme tiredness, injection site is a tennis ball welt (flu-like symptoms, took ibuprofen all day). 3rd day, better, but injection site is still sore and tennis ball size welt, some itchiness around welt. 4th day, injection site still sore and tennis ball size welt, some itchiness around welt. 5th day, unknown.
Experienced all symptoms listed as possible except vomiting. Most symptoms faded by the 5th day, but then developed cough. Tingling, numbness in both hands and arms lasted for several weeks. Difficulty breathing lasted several weeks. Cough lessened and then worsened until doctor prescribed a series of medications to control the cough, which eventually worked, but not before I was sent to respiratory specialist. Diagnosed with bronchitis which I will have for the rest of my life. Still cough on a daily basis, but not nearly so bad as it was over the two months following the vaccination. Numbness has finally disappeared but still have difficulty breathing during exercise.
Breakthrough case after Covid vaccination. Dose #1 2/25/2021 Dose #2 03/18/2021. C/O muscle aches, runny nose, sore throat, cough, and nausea
when she woke up in the morning her gum on her right face was swollen; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 06Jan2021 at a single dose (at the age of 41-years-old) for COVID-19 immunization. Medical history included high blood pressure. Concomitant medication included amlodipine for high blood pressure. The patient took the COVID vaccine and worked at the hospital six days after the first dose, when she woke up in the morning her gum on her right face was swollen (12Jan2021) and she took the vaccine on left side. She figured it was something with her gum and it was not related. She went to the dentist and everything, and he (dentist) cleared that nothing was wrong with her gum. The patient did not receive treatment for the event. The outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the temporal relationship, the association between the event "gum on her right face was swollen" with BNT162b2 can not be fully excluded.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Friday: Before I left facility I started tingling around my mouth but ignored. When I got home my arthritic places that always hurt started intensifying more than usual but not my injection arm.  Started itching on my head and went down in different spots on my body. Never had hives except from scratching. Took 1  otc Benadryl when continued itching then again at bedtime. They helped but not 100%. Saturday: Woke up in the morning with more itching, headache, fatigue.Eyes burning for three days, Continued Benadryl and Tylenol for headache and joint aches. No fevers. Monday: went to urgent care. They first gave me a Zyrtec, then 30 minutes later gave me a steroid IM. Did urine test. Prescribed: dexamethazone 4mg. 1 in the morn for 5 days, singular 10 mg. Daily, Zyrtec 10 mg. Daily.  Drink lots of water. Each morning after I went to urgent care I?d wake up itching until Friday morning. Itching has improved. Took my last script this morn on Saturday. First day not fatigued and very sleep was Thursday. The other days before I slept a lot.  I?m just concerned if it will be okay to take the second dose. I have it on March 19.
pfizer #1 on 2/25/2021 weakness 3/20/2021 subsequently determined by neurologist after MRI and lumbar puncture and serologies June 2021 to be Guillaine Barre
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients. No demographic information was provided. COMVAX (lot number not provided) was improperly stored. The improper storage started on 29-DEC-2012. The improperly stored COMVAX may have been administered to an unspecified number of patients on unspecified dates. No adverse event reported. This is one of several reports from the same source (other case IDs 1306USA008658, 1307USA0089544, 1307USA008945, 1307USA008946, 1307USA008948 and 1307USA008949). Additional information has been requested.
7:15 am woke up very tired and no energy. When home from school at 3:45 feeling achy and slept for two hours. Awoke at 5:45pm  with headache and worse body aches. Temperature with thermometer under tongue was 102.0 F. Continued feeling not well. Back to sleep in bed at 7:30pm with body aches, headache, and overall feeling unwell.
patient's wife reported that he passed out in a restaurant about an hour after he left the pharmacy and received his vaccine. He started to feel bad and stood up from his seat to use the resteroom and fainted. The staff called and ambulance but he refused to go to the hospital. Patient's wife reports the EMT's did check him over and said his vitals were okay and appeared fine. His wife then met him and took him home to rest.
Received Consentyx during Moderna COVID series; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Received Consentyx during Moderna COVID series) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 012M20A) for COVID-19 vaccination.     Concomitant products included SECUKINUMAB (COSENTYX) from 21-Jan-2021 to an unknown date for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2. On 21-Jan-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Received Consentyx during Moderna COVID series). On 21-Jan-2021, INTERCHANGE OF VACCINE PRODUCTS (Received Consentyx during Moderna COVID series) had resolved.            Concomitant product use included Consentyx. No Treatment information provided.
This spontaneous report was received from a pharmacist regarding a female patient of unknown age. There was no information about concurrent condition and historical medication. On 17-NOV-2015 the patient was vaccinated with PNEUMOVAX 23. No concomitant medication was reported. On an unknown date in November 2015, the patient experienced soreness in her arm, redness on the top of her shoulder and back of her arm, like welts. It was unknown if there was any lab work. It was stated that as of 18-NOV-2015, it was unknown if the patient continues on PNEUMOVAX 23. The outcome of soreness in her arm, redness on the top of her shoulder and back of her arm, like welts was reported as not resolved. Causality between PNEUMOVAX 23 and soreness in her arm, redness on the top of her shoulder and back of her arm, like welts was unknown. Additional information has been requested.
Pt with immediate pain, numbness/tinging/aching at injection side and hand on same side for 6+ days.  Per PCP, likely caused by incorrect placement of vaccination. Pt given sulindac and plan for EMG if no improvement.
2.5 hrs p/administration of vax, pt exhibited clenched, rigid jaw & strained breathing duration 5-10 seconds;
12/5/14 - PC from mom, states that pt had severe abdominal pain resulting in MD visit with Dr. Mom states pt was given something to drink with lidocaine in it. Abd. pain x 48 hrs. Mom states looking back this occurred after 1st dose also no MD visit. Same adverse events also occurred with pt's sister - no MD visit needed.
Injection arm very sore. Started three to four hours after injection. Hard to move arm. It is now 20 hours after injection and arm is still very stiff and sore. Still have trouble lifting arm above shoulder height due to soreness.
tingling in the hands; breathing problems; Anxiety; Numbness; Sensation of throat closing/difficulty in swallowing in the throat; This spontaneous case was reported by a pharmacist and describes the occurrence of PARAESTHESIA (tingling in the hands), DYSPNOEA (breathing problems), ANXIETY (Anxiety), HYPOAESTHESIA (Numbness) and THROAT TIGHTNESS (Sensation of throat closing/difficulty in swallowing in the throat) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and CELECOXIB (CELEXA [CELECOXIB]) for an unknown indication.    On 06-May-2021 at 5:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced THROAT TIGHTNESS (Sensation of throat closing/difficulty in swallowing in the throat). On 06-May-2021 at 5:00 PM, the patient experienced PARAESTHESIA (tingling in the hands), DYSPNOEA (breathing problems), ANXIETY (Anxiety) and HYPOAESTHESIA (Numbness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) ongoing from 06-May-2021 at a dose of 10 ml. On 06-May-2021, THROAT TIGHTNESS (Sensation of throat closing/difficulty in swallowing in the throat) had resolved. On 06-May-2021 at 6:00 PM, PARAESTHESIA (tingling in the hands), DYSPNOEA (breathing problems), ANXIETY (Anxiety) and HYPOAESTHESIA (Numbness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-May-2021, Blood pressure measurement: 140/90 mmHg (Inconclusive) interpretation not provided. On 06-May-2021, Body temperature: 97 degrees fahrenheit (Inconclusive) interpretation not provided. On 06-May-2021, Heart rate: 85 beats per minute (Inconclusive) interpretation not provided.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered PARAESTHESIA (tingling in the hands), DYSPNOEA (breathing problems), ANXIETY (Anxiety), HYPOAESTHESIA (Numbness) and THROAT TIGHTNESS (Sensation of throat closing/difficulty in swallowing in the throat) to be possibly related.    Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: initial additional. On 23-Jul-2021: initial additional.
A non-serious spontaneous report of 8 month old infant was inadvertently administered H1N1 LAIV was received from a nurse/health professional concerning an eight-month-old female. Patient was reported to have no relevant medical history and no concomitant medications were consumed. On 5-Dec-2009, the patient received H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable and the event was considered resolved. Additional information was received on 23-Dec-2009 and incorporated into the narrative: The information regarding reporter, patient's medical history and concomitant medications was included into the narrative.
Information ahs been received from a physician concerning a 16 year old female patient who on 15-JUN-2007 was vaccinated with a first dose of Gardasil. On 15-JUN-2007, the patient experienced a vasovagal reaction. Unspecified medical attention was sought. On 15-JUN-2007, the patient recovered. No product quality complaint was involved. Additional information has been requested.
Left arm redness where vaccine was administered. Painful lymph node very swollen into breast tissue and I have a lot of pain in the arm.
Tingling in right hand fingers  progressed over then next week to right side of body and worsening to numbness, especially in right hand. Eventually, referred to neurologist where MRIs show myolitis (inflammation in the spinal cord from C2-C4) and white spots on brain.  These issues suggest MS.  On 10/15/2009, started 3 days of intravenous steroids followed by oral Prednisone.
Intense pain in arm; weakness in arm - unable to lift small objects, continued since onset, with the exception of the first day dosage of a steroid perscribed by family doctor for the pain, weakness and tingling and loss of feeling in hand. Continuing pain, unable to lift arm, sleep on arm, difficulty raising arm to dress and undress.
Five hours after injection I got nauseous, little dizzy, abdominal cramps (severe), fever, chills, body aches (severe back and side pain). Lasted two days.
Accidental Sub Q injection of MENcn-ACYW vaccine; 4 x 3 cm Red tender indurated Area at site of Sub Q injection left ventral forearm; Advised ice, NSAIDS prn.
I developed a rash on my arms, stomach and back on Tuesday.  I took Benadryl and it was effective. I again developed a rash on Wednesday and Thursday night. Went away with Benadryl. No rash today.
Patient experienced redness in a circular pattern around the injection site which grew larger as time passed. The area was swollen, warm to the touch and sensitive to pressure.
Patient was admitted to Emergency Department 41 days after receiving COVID dose #2. Patient was admitted to hospital 1 day after ED admit.
arm and shoulder soreness; sore shoulder; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 21Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 21Apr2021, outcome "recovered" (23Apr2021), described as "arm and shoulder soreness"; ARTHRALGIA (non-serious) with onset 21Apr2021, outcome "recovered" (23Apr2021), described as "sore shoulder".  Additional information: Reporter states the arm and shoulder soreness was just like the other 2 times, it last for 2 days.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101807341 same patient/drug, different AE and dose.;US-PFIZER INC-202101804704 same patient/drug, different AE and dose.
pain; This is a spontaneous report from a contactable consumer (patient). A 77-years-old female patient received bnt162b2 (COMIRNATY, solution for injection, Batch/Lot Number: EN5318, expiry date: 31May2021), via an unspecified route of administration in left arm on 12Feb2021 (at the age of 77-years) as dose 1, single for COVID-19 immunization. Medical history includes bad fall, operation and broke her left collarbone (she fell 4 years ago, broke her left collarbone, and had a titanium rod placed). About 4 years ago, she had a bad fall taking care of an old gentleman. The patient had a titanium plate placed because her collar bone was pretty bad off and had no trouble or pain with the titanium plate since it was placed; the only thing was that one of the screws in the plate stuck out a little bit, it did not hurt, just almost felt like something stuck upward. Concomitant medications were not reported. It was reported that on Feb2021 (starting 16Feb2021 or 17Feb2021), the titanium plate the patient had placed about 4 years ago was visible and hurts. It was almost like the flesh was being sucked underneath the titanium plate, there was like no blood or anything but there was a hole and it was kind of scary. The patient did not know if that was coincidental or related to Pfizer COVID-19 Vaccine but wanted to ask if it was possible it could be related to the Pfizer COVID-19 Vaccine. The patient said her 86 y/o (year-old) sister received the vaccine and her arm was very sore 5 days after receiving it. The outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
Pain, redness, swelling, inflammation, red spots around injection site. Per her MD possible infection - will likely put her on antibiotics.
1/20/06 "superficial calf pain, then severe calf pain 1/25/06. MD told patient of her "superficial vein thrombosis" secondary to Hepatitis B vaccine. After 3 weeks, bed rest, recovered, but vein remain sclerosed. Info per MD.
Received Pfizer shot at 3pm 9/27/21. Felt itchiness on back night of 9/28/21. Itchiness bad enough to call primary care doctor & made appt for 10/4/21. Dr diagnosed rash as Shingles & prescribed Valacyclovir HCL 1gm (total 14 pills). Those were taken as prescribed. Rash continued to get worse through 10/24/21. Rash continued through today but not as bad. However, pain & itchiness remain significant through today 10/29/21.
Left shoulder w/ firm, red, warm, painful induration measures 8cm x 12cm.
Swelling at vaccine site , general aches mild chills for about 12 hours. Swelling lasted 24 hours.  Self medicated with Tylenol.
Several minutes after administering vaccine, PT reported nausea and dizziness.  Vital signs were within Normal limits and PT recovered after drinking juice and eating crackers
Physician ordered Tdap( Adacel ) and the medical assistant gave Dtap (Infanrix) in error. The manufacturer contacted and possible adverse reactions explained Pt. informed about error and possible adverse reaction of fever, aching, malaise, headache and muscle aching.  Pt informed to contact us immediatley if he experiences and of the above symptoms.
Chills, fatigue, and fever. Symptoms began about eleven hours after injection and lasted for about ten hours.
Pt recvd Engerix-B & had allergic phenomena including welts extending on chest & arm swelling;
Redness larger than half dollar with center raised similar to boil.  Measured 4x4mm by MD to left forearm.  This was described to me by client.
pt's child recv vax;devel vesicular rash 6jul95;22jul95 devel vesicular rash w/ approx 100 lesions;MD said possibly contracted virus & broke out in gen varicella rash;underwent therapeutic abortion;specimens analysis revealed vax strain;
Multiple nodules in the right side of the neck, around 1 cm; This is a spontaneous report from a contactable pharmacist (patient). A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on 09Jan2021 (at the age of 40years) at single dose for Covid-19 immunization. The patient's medical history was not reported; no known allergies. Concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced multiple nodules in the right side of the neck, around 1 cm on 15Jan2021. The adverse event result in Doctor or other healthcare professional office/clinic visit. It was unknown if treatment was received for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The outcome of event was unknown.  Information on the batch/lot number has been requested.
Acute disseminated infectious encephalomyelitis.  Symptoms included headache, weakness, fatigue, difficulty concentrating, body aches, chills, arm and leg numbness.   Treated with solumedrol infusion.
Initial unsolicited report received from a pharmacist on 24 October 2016. This case involves six patients (age and gender were not reported) who were vaccinated with Fluzone QIV (lot number: UI693AB, expiry date: 30 Jun 2017, route, site of administration, dose and dose in series were not reported) and dose of Pneumovax vaccines (lot number, expiry date, route, site of administration, dose and dose in series were not reported) on 20 October 2016. The medical history and concomitant medications were not reported. The illness at the time of vaccination was reported as none. On 20 October 2016 i.e, on same day of following vaccination, the patients experienced redness, swelling discomfort at injection site, and chills and body aches (Reported as after several hours of vaccination). On 21 October 2016, post vaccination, the patient "didn't feel well". The laboratory test and the corrective treatment were not reported. The outcome of the events was reported as unknown. List of the documents held by sender: none.
Information has been received from the author of a literature article, referring to a 41 year-old female patient diagnosed with multiple sclerosis (MS) and optic neuritis at age 39. She presented with a history of Hashimoto's thyroiditis, recurrent non-menstrual toxic shock syndrome, recurrent sinusitis, and acute episodes of thrush, shingles, cellulitis, and gastroenteritis. CD19+CD27- transitional B cells were decreased but lymphocyte mitogen/antigen stimulation was normal. IgM was decreased (27 - 36 mg/dL) with a poor pneumococcal vaccine (manufacturer unknown) (dose, lot # and expiration date not reported) response. CH50, IgG, IgA, and protein-based vaccine response were normal. The outcome of the event was unknown. The causality between pneumococcal vaccine (manufacturer unknown) and the event was related. This is one of several reports received from the same literature (linked case# 1705USA000607). Additional information has been requested. Sender's Comments: US-009507513-1705USA000607.
Patient had influenza vaccine on 10/3/08. Three days later, patient reported symptoms of cough, sinus infection, chills, and a urinary tract infection.  Paitent sought treatment for the urinary tract infection and was placed on Bactrim DS 1 tab 2x/day for 10 days.
Pt reported that she had usual muscle soreness from flu vaccine administered that did not go away - sought evaluation in December 2019 due to limited range of motion in left arm.  Referred to PT.
About 20-30 minutes after injection, warm tingling feeling in throat, difficulty swallowing. Took 3 ADVIL PM, and was found to be relieved when I awoke 5 hours later (did not have plain BENADRYL at home).
Information has been received from a physician concerning a 40 year old female who on 16-MAY-2007 was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (Lot# 649674/0239R). Concomitant therapy included tetracycline and NEOPSORIN FIRST AID OINTMENT. On 31-MAY-2007, the patient developed a maculopapular rash looked like measles and had cervical lymphadenopathy. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint. Additional information is not expected.